[1] WAHLUND L, COWBURN R, WINBLAD B, et al. Therapeutic Strategies in Alzheimer’s Disease[C]. 1900: 0. DOI:
10.1007/978-1-4615-8149-9_80[2] T IWATSUBO. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).[J]. Neuron, 1994, 13 1: 45-53. DOI:
10.1016/0896-6273(94)90458-8[3] D. O. T. ALAWODE. Alzheimer’s Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint[J]. Frontiers in Neuroscience, 2022. DOI:
10.3389/fnins.2022.837390[4] JOANNA L JANKOWSKY H Z. Practical considerations for choosing a mouse model of Alzheimer’s disease.[J]. Molecular Neurodegeneration, 2017: 89. DOI:
10.1186/s13024-017-0231-7